Pre-exposure prophylaxis against rabies in children : Safety of purified chick embryo cell rabies vaccine (Vaxirab N) when administered by intradermal route

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 9, 2013, Pages 1910-1913

  Ravish, Haradanahalli S ^a   Srikanth, Jayanthi ^a   Ashwath Narayana, Doddabele Hanumanthaiah ^a   Annadani, Rachana ^a   Vijayashankar, Veena ^a   Undi, Malatesh ^a  

^a KEMPEGOWDA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Children; Intradermal rabies vaccination; Pre exposure prophylaxis; Purified chick embryo cell rabies vaccine; Rabies

Indexed keywords

RABIES VACCINE; UNCLASSIFIED DRUG; VAXIRAB N;

ALLERGY; ANIMAL CELL; ARTICLE; CHICK; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE CONTROL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EMBRYO; FATIGUE; FEMALE; FEVER; HUMAN; IMMUNOGENICITY; INDIA; INJECTION SITE PAIN; INJECTION SITE PRURITUS; MALE; MYALGIA; NONHUMAN; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRESCHOOL CHILD; RABIES; SCHOOL CHILD; VACCINATION; VACCINE PRODUCTION;

CHILDREN; INTRADERMAL RABIES VACCINATION; PRE EXPOSURE PROPHYLAXIS; PURIFIED CHICK EMBRYO CELL RABIES VACCINE; RABIES;

ANIMALS; CHICK EMBRYO; CHILD; CHILD, PRESCHOOL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INDIA; INJECTIONS, INTRADERMAL; MALE; PREVALENCE; RABIES; RABIES VACCINES; URBAN POPULATION; VACCINATION;

EID: 84884626260     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.25203     Document Type: Article

References (15)

1. World Health Organization. Rabies vaccines: WHO position paper, Weekly Epidemiological Record, No. 32, 2010, 85:309-20.
2. Sudarshan MK, Madhusudana SN, Mahendra BJ, Rao NS, Ashwath Narayana DH, Abdul Rahman S, et al. Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey. Int J Infect Dis 2007; 11:29-35; PMID:16678463; http://dx.doi.org/10.1016/j.ijid.2005.10.007
3. National Institute of Communicable Diseases, Ministry of Health & Family welfare. National guidelines for rabies prophylaxis and intra-dermal administration of cell culture rabies vaccines. New Delhi, India. 2007.
4. World Health Organization. WHO expert consultation on rabies. TRS 931. WHO Geneva 2005.
5. Suwansrinon K, Wilde H, Benjavongkulchai M, Banjongkasaena U, Lertjarutorn S, Boonchang S, et al. Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity. Vaccine 2006; 24:3878-80; PMID:16530893; http://dx.doi.org/10.1016/j. vaccine.2006.02.027
6. Gherardin AW, Scrimgeour DJ, Lau SC, Phillips MA, Kass RB. Early rabies antibody response to intramuscular booster in previously intradermally immunized travelers using human diploid cell rabies vaccine. J Travel Med 2001; 8:122-6; PMID:11468113; http://dx.doi.org/10.2310/7060.2001.24445
7. Sudarshan MK, Ravish HS, Ashwath Narayana DH. Time interval for booster vaccination following reexposure to rabies in previously vaccinated subjects. Asian Biomedicine 2011; 5:589-93
8. World Health Organization. Human and dog rabies prevention and control, Report of the WHO/Bill & Melinda Gates foundation consultation, Annecy, France, 2009.
9. Lang J, Duong GH, Nguyen VG, Le TT, Nguyen CV, Kesmedjian V, et al. Randomised feasibility trial of preexposure rabies vaccination with DTP-IPV in infants. Lancet 1997; 349:1663-5; PMID:9186385; http://dx.doi.org/10.1016/S0140- 6736(96)10085-4
10. Shanbag P, Shah N, Kulkarni M, Juvekar M, Madhusudana SN, Vakil HB, et al. Protecting Indian schoolchildren against rabies: pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV). Hum Vaccin 2008; 4:365-9; PMID:18398307; http://dx.doi.org/10. 4161/hv.4.5.5987
11. Kamoltham T, Thinyounyong W, Phongchamnaphai P, Phraisuwan P, Khawplod P, Banzhoff A, et al. Preexposure rabies vaccination of children in Thailand using Purified Chick Embryo Cell Rabies Vaccine intra dermally is immunogenic and safe. J Pedod 2007; 151:173-7; http://dx.doi.org/10.1016/j.jpeds.2007.02.044
12. A clinical evaluation of safety and immunogenicity of purified chick embryo cell rabies vaccine (Vaxirab N) administered intradermally as pre exposure prophylaxis in healthy volunteers. 2010, India.
13. A clinical evaluation of safety and immunogenicity of purified chick embryo cell rabies vaccine (Vaxirab N) administered intramuscularly as post exposure prophylaxis in animal bite cases. 2011, India.
14. A clinical evaluation of safety and immunogenicity of purified chick embryo cell rabies vaccine (Vaxirab N) administered intradermally as post exposure prophylaxis in animal bite cases. 2011, India.
15. Current strategies for human rabies pre and postexposure prophylaxis 2010, Available at: www.who.int/rabies/human/WHO-strategy-prepost-exposure/en/ html accessed on: 12.01.2013.